Back

Long-term incidence and efficacy of appropriate therapy in subcutaneous and transvenous implantable cardioverter-defibrillators: A secondary analysis of the PRAETORIAN-XL trial

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Implantable cardioverter-defibrillator therapy in contemporary practice: outcomes, predictors, and expanding indications Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yasuhiro Matsuda

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
High right ventricular pacing burden is associated with heart failure following leadless pacemaker implantations
Doctor H. Iwakawa (Adelaide, AU)
Abstract
Presentation thumbnail
Lean BMI shifts the mortality landscape toward pump failure in japanese heart failure patients with primary-prevention high-voltage devices: a post hoc analysis of the HINODE Registry
Doctor M. Asami (Tokyo, JP)
Abstract
Presentation thumbnail
Persistent sex gap in inpatient ICD utilization during HFrEF admissions: national trends 2018–2022
Doctor V. Polana (Brooklyn, US)
Abstract
Presentation thumbnail
Impact of right ventricular pacing burden on shocks in patients with implantable cardioverter defibrillators
Doctor H. Iwakawa (Adelaide, AU)
Abstract
Presentation thumbnail
Individualized baseline modelling of implantable cardioverter defibrillators remote monitoring data detects deviations preceding ventricular arrhythmias
Doctor T. Ito (Sendai, JP)
Abstract

Access the full session

Session thumbnail
Implantable cardioverter-defibrillator therapy in contemporary practice: outcomes, predictors, and expanding indications

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Reevaluating the long-term efficacy of primary prophylactic implantable cardioverter-defibrillators for sudden cardiac death in the era of advanced heart failure treatment
31 August 2025
thumbnail
Congress Presentation
PRAETORIAN/ATLAS: Inappropriate shock with S-ICD vs. transvenous ICD
29 August 2025
thumbnail
Congress Presentation
Pain after subcutaneous ICD implantation: a secondary analysis of the PRAETORIAN-DFT trial
31 March 2025
thumbnail
Congress Presentation
Induced versus spontaneous ventricular fibrillation in subcutaneous ICD recipients: impact on sensing and therapy delivery
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources